ENVOY MEDICAL, INC. (COCH) Debt Components
- 2025-12-31: Line of Credit Facility, Increase, Accrued InterestUSD 12 month · $29.44M; Debt Instrument, Unused Borrowing Capacity, AmountUSD (m); Debt Instrument, Unamortized DiscountUSD (m); Long Term Debt Average Amount OutstandingUSD (m).
- 2025-09-30: Line of Credit Facility, Increase, Accrued InterestUSD 9 month · $29.44M; Debt Instrument, Unused Borrowing Capacity, AmountUSD (m); Debt Instrument, Unamortized DiscountUSD (m); Long Term Debt Average Amount OutstandingUSD (m).
- 2025-06-30: Line of Credit Facility, Increase, Accrued InterestUSD (m); Debt Instrument, Unused Borrowing Capacity, AmountUSD (m); Debt Instrument, Unamortized DiscountUSD $2.70M; Long Term Debt Average Amount OutstandingUSD (m).
- 2025-03-31: Line of Credit Facility, Increase, Accrued InterestUSD (m); Debt Instrument, Unused Borrowing Capacity, AmountUSD (m); Debt Instrument, Unamortized DiscountUSD (m); Long Term Debt Average Amount OutstandingUSD 3 month · $4.30M.
ENVOY MEDICAL, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Line of Credit Facility, Increase, Accrued Interest USD | Debt Instrument, Unused Borrowing Capacity, Amount USD | Debt Instrument, Unamortized Discount USD | Long Term Debt Average Amount Outstanding USD | Debt Instrument Issued Principal USD | Convertible Notes Payable, Current USD | Convertible Notes Payable USD | Notes Payable USD | Line of Credit Facility, Maximum Borrowing Capacity USD | Line of Credit Facility, Interest Rate During Period pure | Line of Credit Facility, Annual Principal Payment USD | Debt Instrument, Fair Value Disclosure USD | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD | Notes Payable, Fair Value Disclosure USD | Notes Payable, Related Parties USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 12 month · $29.44M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | 9 month · $29.44M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | (m) | $2.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | (m) | 3 month · $4.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | $1.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | $1.28M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-05-23 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $197.00K | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $5.00M | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $2.50M | (m) | $4.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | $4.00M | $4.00M | $4.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-04-17 | (m) | $4.00M | (m) | (m) | $4.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-04-17 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $10.00M | 4.50% | (m) | (m) | (m) | (m) | (m) |
| 2023-04-03 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $734.30K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.23M | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | $448.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.50M | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.50M | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $750.00K | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $185.58K |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $13.80K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| Bone Biologics Corp (BBLG) | United States | $0.001B | |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |